货号 | 9322S |
反应种属 | Human/Mouse/Rat |
来源宿主 | Rabbit |
应用 | W/IP |
目标/特异性 | Phospho-GSK-3-beta (Ser9) (D3A4) Rabbit mAb detects endogenous levels of GSK-3-beta only when phosphorylated at Ser9. |
使用方法 | WB(1:1000) IP (1:50) |
供应商 | CST |
背景 | Glycogen synthase kinase-3 (GSK-3) was initially identified as an enzyme that regulates glycogen synthesis in response to insulin (1). GSK-3 is a ubiquitously expressed serine/threonine protein kinase that phosphorylates and inactivates glycogen synthase. GSK-3 is a critical downstream element of the PI3 kinase/Akt cell survival pathway whose activity can be inhibited by Akt-mediated phosphorylation at Ser21 of GSK-3α and Ser9 of GSK-3β (2,3). GSK-3 has been implicated in the regulation of cell fate in Dictyostelium and is a component of the Wnt signaling pathway required for Drosophila, Xenopus, and mammalian development (4). GSK-3 has been shown to regulate cyclin D1 proteolysis and subcellular localization (5). |
存放说明 | -20C |
计算分子量 | 46 |
Western blot analysis of extracts from NIH/3T3 cells, lambda-phosphatase or PDGF-treated, using Phospho-GSK-3-beta (Ser9) (D3A4) Rabbit mAb (upper) or GSK-3-beta (27C10) Rabbit mAb #9315 (lower). Western blot 分析NIH/3T3 细胞, λ磷酸酶和PDGF处理组,所用抗体为Phospho-GSK-3β (Ser9) (D3A4) Rabbit mAb兔单抗 (上) 或GSK-3β (27C10) Rabbit mAb兔单抗 #9315 (下)。 | |